510(k) K181334
K181334 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "ADVIA Centaur Herpes-2 IgG". The FDA issued a decision of Substantially Equivalent on August 23, 2018. The device falls under product code MYF (Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2), a Class II device regulated under 21 CFR 866.3305. Biokit, S.A. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 23, 2018
- Date Received
- May 21, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type